BORTEZOMIB BAXTER 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG

Baxter Holding B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2b1be9dc2b75f64c
Drug Cima Aemps Name: BORTEZOMIB BAXTER 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG
Register Number: 86601
Holder Company Name: Baxter Holding B.V.
Marketing Company Name: Baxter S.L.
Holder Company Detail Path: /organization/baxter-holding-bv
Authorization Date: 2022-03-03
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 3,5 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Baxter Holding B.V.
Company Detail Path: /organization/baxter-holding-bv

BORTEZOMIB

3,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 3, 2022

Approval ID

2b1be9dc2b75f64c

Type

Standard